top of page
ViiV
Description:
Juluca is ViiV Healthcare’s first 2-drug regimen, once-daily, single-pill that combines the integrase strand transfer inhibitor (INSTI) dolutegravir, with the non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine.
Triumeq is a once-daily single-pill dolutegravir-based regimen, containing the booster-free integrase strand transfer inhibitor (INSTI) dolutegravir and the nucleoside reverse transcriptase inhibitors (NRTIs) abacavir and lamivudine, which can be conveniently taken with or without food and may be taken at any time of day.
And my role was supporting E-mail application, Banner storyboard and Testimonial page designs.
Agency:
McCANN Echo
Job Description:
Graphic Design
Client:
ViiV
Period:
2017 AUG
bottom of page